TY  - GEN
AU  - Kajosaari,Lauri I
AU  - Jaakkola,Tiina
AU  - Neuvonen,Pertti J
AU  - Backman,Janne T
TI  - Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide
SN  - 0031-6970
PY  - 2006///1030
KW  - Administration, Oral
KW  - Adult
KW  - Area Under Curve
KW  - Aryl Hydrocarbon Hydroxylases
KW  - antagonists & inhibitors
KW  - Blood Glucose
KW  - metabolism
KW  - Capsules
KW  - Carbamates
KW  - blood
KW  - Chromatography, Liquid
KW  - methods
KW  - Cross-Over Studies
KW  - Cytochrome P-450 CYP2C8
KW  - Cytochrome P-450 CYP3A
KW  - Cytochrome P-450 Enzyme Inhibitors
KW  - Cytochrome P-450 Enzyme System
KW  - Drug Administration Schedule
KW  - Enzyme Inhibitors
KW  - Female
KW  - Gas Chromatography-Mass Spectrometry
KW  - Half-Life
KW  - Humans
KW  - Hypoglycemic Agents
KW  - administration & dosage
KW  - In Vitro Techniques
KW  - Male
KW  - Pioglitazone
KW  - Piperidines
KW  - Substrate Specificity
KW  - Thiazolidinediones
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00228-005-0093-8
ER  -